1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 18 APRIL 2016

Cancer Drug News 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Roche To Make High-Impact Entry Into PD-1/PD-L1 Arena
Industry Brief - Keytruda Gains FDA Breakthrough Therapy Designation For cHL
Industry Brief - FDA Accepts BMS' Opdivo sBLA In cHL
Industry Trend Analysis - Celgene Augments Long-Term Outlook
Industry Brief - FDA Grants Accelerated Approval To Venclexta In CLL
Industry Trend Analysis - AstraZeneca To Benefit From Clovis Setback
Industry Brief - QIAGEN/Mirati To Co-Develop Novel Companion Diagnostic In NSCLC
Industry Brief - Brigatinib Phase III Trial Initiated In ALK-Positive NSCLC Patients
Industry Brief - FDA Accepts Keytruda sBLA In Recurrent/Metastatic HNSCC For Review
Industry Brief - Boehringer Ingelheim Exercises Option on Second Oncology Target Discovery
Industry Brief - Heptares/Kymab Collaborate On Novel Antibody Therapeutics
Industry Brief - Presage Extends Oncology Research Collaboration With Takeda
Industry Brief - MSD/Taiho Enter Pembrolizumab Co-Promotion Deal In Japan
Industry Trend Analysis - Digital Healthcare Transformation Enhanced Through Cognitive Computing
Industry Brief - Leica/Merrimack To Co-Develop HRG Diagnostic For Seribantumab
Industry Trend Analysis - Bioinformatics Will Aid In QIAGEN Returning To Growth

Table Of Contents

Cancer Drug News 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.